SPP1 and head and neck cancer: These interesting results are a motivation to measure plasma OPN prospectively in future clinical trials of treatments targeted at hypoxic tumor cells or retrospectively in stored plasma samples from other relevant patient groups and compare the results to plasma OPN levels reported for head and neck cancer patients.